GlassScriptPhysician profile
Amy B Goorman
NPI 1922108083
$4,642.44
in general payments reported to CMS, 2019-2025
36 companies · $1,713 in 2025
The $1,713 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $487 · 2022: $468 · 2023: $840 · 2024: $1,136 · 2025: $1,713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,080 · Travel and Lodging: $540 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,080.06 |
| Travel and Lodging | $539.89 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,033.80 | 2021-2025 | Rezum Generator, Ams 700, Lithovue |
| Sumitomo Pharma America, INC. | $409.60 | 2023-2025 | Orgovyx, Gemtesa |
| Procept Biorobotics Corporation | $394.85 | 2024-2025 | Aquabeam System |
| Janssen Biotech, INC. | $350.96 | 2021-2025 | Erleada, Akeega, Balversa |
| Coloplast Corp | $275.91 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $231.36 | 2021-2025 | Provenge |
| Myovant Sciences INC. | $176.56 | 2021-2022 | |
| Astellas Pharma US INC | $169.89 | 2021-2024 | Xtandi |
| Endo Pharmaceuticals INC. | $168.78 | 2021-2023 | Aveed, Xiaflex, Edex |
| Myriad Genetic Laboratories, INC. | $159.53 | 2022-2025 | Prolaris |
| Urogen Pharma, INC. | $137.89 | 2023-2025 | Jelmyto |
| Palette Life Sciences, INC. | $127.33 | 2021 | |
| Endo USA, INC. | $102.74 | 2024-2025 | Xiaflex, Aveed |
| Amgen INC. | $75.45 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $70.45 | 2024 | Adstiladrin |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $62.47 | 2023-2025 | Jatenzo, Eligard |
| Medtronic, INC. | $61.58 | 2022 | |
| Blue Earth Diagnostics | $60.38 | 2021-2022 | |
| Axonics, INC. | $57.33 | 2023-2024 | Bulkamid, Axonics |
| Olympus America INC. | $51.54 | 2024-2025 | Itind System |
| Foundation Medicine, INC. | $46.82 | 2021-2023 | Foundationone Liquid Cdx |
| Telix Pharmaceuticals | $45.02 | 2024 | Illuccix |
| Accord Healthcare, INC. | $40.27 | 2023-2024 | |
| Cycle Pharmaceuticals INC | $35.15 | 2025 | Venxxiva |
| Tolmar Pharmaceuticals, INC. | $31.89 | 2021-2022 | |
| Edap Technomed INC | $29.98 | 2025 | |
| Sun Pharmaceutical Industries INC. | $29.44 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.96 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $24.76 | 2024 | |
| Janssen Scientific Affairs, LLC | $24.41 | 2024 | Erleada, Pipeline |
| Progenics Pharmaceuticals, INC. | $24.34 | 2024 | |
| Verity Pharmaceuticals INC. | $24.05 | 2025 | Trelstar |
| Antares Pharma, INC. | $22.60 | 2024 | Xyosted |
| Immunitybio, INC. | $20.66 | 2025 | |
| Alexion Pharmaceuticals, INC. | $17.95 | 2021 | |
| Photocure INC | $17.74 | 2024 | Cysview |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Goorman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.